Asenapine Maleate
6 NDCs across 2 manufacturers|3 Generic,3 Brand
Asenapine Maleate is used to treat bipolar disorder and schizophrenia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Aug 13, 2009, and the first generic was approved Dec 10, 2020. FDA's Orange Book lists 11 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $25 million on Asenapine Maleate across 72,000 claims for 11,000 beneficiaries.
Asenapine Maleate is available as 6 NDCs from 2 manufacturers (3 generic, 3 brand), with NADAC prices from $2.03 to $21.16 per EA — the most expensive product costs about 10× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
6
3G / 3B
Manufacturers
2
competing in market
Price Spread
$2.03 – $21.16
per EA
7d Activity
avg -2.8% WoW · of 6 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Allergan, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Atypical Antipsychotic class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing ASENAPINE MALEATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SAPHRIS 5 MG TAB SUBLINGUAL | $21.1606 per EA | -0.10% |
SAPHRIS 10 MG TAB SUBLINGUAL | $21.1593 per EA | 0.00% |
SAPHRIS 2.5 MG TAB SUBLINGUAL | $20.9944 per EA | 0.00% |
ASENAPINE 2.5 MG TABLET SL | $3.0881 per EA | -0.93% |
ASENAPINE 10 MG TABLET SL | $2.6272 per EA | -10.19% |
ASENAPINE 5 MG TABLET SL | $2.0325 per EA | -5.36% |
Frequently Asked Questions
What is Asenapine Maleate used to treat?
Asenapine Maleate is used to treat bipolar disorder and schizophrenia, per the National Library of Medicine's MED-RT classification.
When did Asenapine Maleate become available as a generic?
FDA approved the first generic Asenapine Maleate (ANDA) on Dec 10, 2020. The Orange Book currently lists 11 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Asenapine Maleate?
In 2024, Medicare Part D spent $25 million on Asenapine Maleate across 72,000 claims for 11,000 beneficiaries.
How many Asenapine Maleate products are on the market?
The Asenapine Maleate drug market contains 6 NDCs from 2 manufacturers — 3 generic and 3 brand products.
What is the price range for Asenapine Maleate?
NADAC reference prices for Asenapine Maleate range from $2.0325 to $21.1606 per EA — the most expensive product costs about 10× the cheapest.
Is generic Asenapine Maleate cheaper than brand?
The average generic NADAC for Asenapine Maleate is $2.5826 per EA, versus $21.1047 for brand-labeled products — brand versions average about 8.2× the generic price.
Which manufacturers make Asenapine Maleate?
2 manufacturers list Asenapine Maleate in NADAC. Ranked by number of NDCs, the largest are Allergan, Inc. (3), Breckenridge Pharmaceutical Inc. (3).
How has the price of Asenapine Maleate changed recently?
Over the past 7 days, 0 Asenapine Maleate NDCs rose and 4 fell, with a market-wide average change of -2.8%.